Institutions / DAFNA Capital Management LLC / Holdings
Back to DAFNA Capital Management LLC

DAFNA Capital Management LLC

All holdings · as of Mar 31, 2026

83 positions

CompanyClassValue ↓Shares% of portfolio
Revolution Medicines, Inc.—$56.47M580,67812.8%
SPDR S&P BIOTECH ETF—$40.68M318,5059.3%
Stereotaxis, Inc.—$25.17M13,680,5545.7%
Day One Biopharmaceuticals, Inc.—$20.98M978,4634.8%
AtriCure Inc—$17.04M597,4313.9%
IDEAYA BIOSCIENCES, INC.—$15.88M476,7403.6%
Xenon Pharmaceuticals Inc.—$14.58M250,7723.3%
Cytokinetics Inc—$14.34M217,4973.3%
COMPASS Pathways plcCMPSADR$13.38M2,418,8823.0%
NEKTAR THERAPEUTICS—$11.88M165,1782.7%
ISHARES NASDAQ BIOTECH INDX—$10.48M62,0952.4%
Arcus Biosciences, Inc.—$9.59M443,8292.2%
NEUROCRINE BIOSCIENCES INC—$9.30M70,6152.1%
Larimar Therapeutics, Inc.—$9.13M2,029,1642.1%
Bicara Therapeutics Inc.—$8.39M421,7331.9%
Axogen, Inc.—$8.28M249,9601.9%
Biohaven Ltd.—$7.15M845,7351.6%
TANDEM DIABETES CARE INC—$6.81M355,2081.5%
Denali Therapeutics Inc.—$6.12M318,5001.4%
ASCENDIS PHARMA A/S—$5.92M4,000,0001.3%
Century Therapeutics, Inc.IPSCCommon Stock$5.50M2,434,3531.3%
Dexcom Inc—$5.42M86,2791.2%
KalVista Pharmaceuticals Inc—$5.38M267,4021.2%
ASCENDIS PHARMA A/S—$5.30M23,1771.2%
MBX Biosciences, Inc.MBXCommon Stock$5.24M175,4651.2%
Inogen Inc—$5.22M845,1791.2%
Syndax Pharmaceuticals Inc—$5.08M217,3551.2%
Alkermes plc.—$4.93M139,4821.1%
Stoke Therapeutics, Inc.—$4.26M130,8751.0%
BIOCRYST PHARMACEUTICALS INC—$4.10M430,2480.9%
GALAPAGOS NV—$3.91M130,1750.9%
Immunovant, Inc.IMVTCommon Stock$3.74M150,5240.9%
Edgewise Therapeutics, Inc.—$3.54M112,2360.8%
MAPLIGHT THERAPEUTICS INCMPLTCommon Stock$3.48M171,0060.8%
Allogene Therapeutics, Inc.—$3.34M1,370,1180.8%
PROCEPT BioRobotics Corp—$3.00M120,0000.7%
Align Technology, Inc.—$2.57M15,0000.6%
PROQR THERAPEUTICS N V—$2.54M1,567,5610.6%
Cybin Inc.—$2.39M498,3610.5%
Rapport Therapeutics, Inc.RAPPCommon Stock$2.35M75,0000.5%
Insulet Corp—$2.28M10,8700.5%
Structure Therapeutics Inc.GPCRADR$2.24M46,5000.5%
IMMATICS NV—$2.22M225,8600.5%
Celldex Therapeutics, Inc.—$2.17M68,5180.5%
Lexeo Therapeutics, Inc.—$2.16M377,0590.5%
Alector, Inc.—$1.95M908,3510.4%
Viking Therapeutics Inc—$1.94M59,5160.4%
Kura Oncology, Inc.—$1.92M235,8680.4%
PROFOUND MEDICAL CORP—$1.70M263,0050.4%
Fulcrum Therapeutics, Inc.—$1.57M205,0000.4%
← PrevPage 1 of 2Next →